Sex Selection Moves to Consumer Culture
By Marcy Darnovsky,
Genetic Crossroads
| 08. 20. 2003
Ads for "Family Balancing" in The New York Times
Several times over the past few months, a small
but striking ad from a Virginia-based fertility clinic has appeared
in the Sunday Styles section of The New York Times. Alongside
a smiling baby, its boldface headline asks, "Do You Want
To Choose the Gender Of Your Next Baby?"
If so, the ad continues, you can join "prospective parents…from
all over the world" who come to the Genetics & IVF
Institute (GIVF) for an "exclusive scientifically-based
sperm sorting gender selection procedure." The technique,
known by the trademarked name MicroSort, is offered as a way
to choose a girl or boy either for the "prevention of genetic
diseases" (selecting against the sex affected by an X-linked
or Y-linked condition) or for "family balancing" (selecting
for a girl in a family that already has one or more boys, or
vice versa).
GIVF
has been promoting MicroSort on its website for several years,
and a few other fertility clinics offer other "family balancing"
methods online. But the MicroSort ads in The New York Times
represent a bolder and higher-profile approach. They mark the...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Emile Torres, Jacobin | 11.15.2025
Watching tech moguls throw caution to the wind in the AI arms race or equivocate on whether humanity ought to continue, it’s natural to wonder whether they care about human lives.
The earnest, in-depth answer to this question is just...
GIVF
has been promoting MicroSort on its website for several years,
and a few other fertility clinics offer other "family balancing"
methods online. But the MicroSort ads in The New York Times
represent a bolder and higher-profile approach. They mark the...